ArticleLancet regional health. Americas2027
Burden of cardiovascular disease in Brazil, 1996-2023: a retrospective descriptive study of the epidemiology and impact on public healthcare.
Article in Lancet regional health. Americas, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiovascular diseases (CVD) are the leading cause of death worldwide, and their epidemiology is correlated with genetic predisposition and exposure to risk. Brazil is a developing country with a vast territory, which leads to structural inequalities. We aimed to comprehensively characterise the epidemiology and burden of CVD in Brazil between 1996 and 2023, examining temporal trends, regional disparities, demographic patterns, healthcare costs, and heart transplantation. Methods: We conducted a nationwide retrospective descriptive ecological study using aggregated administrative data from the Brazilian Unified Health System (SUS), Brazil's publicly funded national health system. Mortality, hospitalization, and heart transplantation data from 1996 to 2023 were analysed according to sex, race/ethnicity, age, and geographic region. We estimated mortality rates for the major CVD, hospital length of stay, healthcare expenditures, and heart transplantation activity. Findings: Acute myocardial infarction remained the leading cause of cardiovascular mortality throughout the study period, while hypertensive diseases overtook heart failure after 2016 as the second leading cause of death. The overall CVD mortality rate-calculated as the number of CVD-related deaths divided by the total population and expressed as a percentage-increased from 7.3% in 1998 to 8.3% in 2023, peaking at 10.1% in 2021. Marked regional, age-, sex-, and race/ethnicity-related disparities were observed, including the complete absence of heart transplantation in the North region throughout the study period. Although hospitalization rates remained relatively stable, CVD-related healthcare expenditures and heart transplantation activity increased over time. Interpretation: CVD remains a major and growing public health challenge in Brazil, with substantial regional and demographic inequalities in disease burden and access to specialised care. These findings highlight the need for targeted public health strategies and more equitable allocation of healthcare resources to reduce cardiovascular morbidity and mortality. Funding: This study was funded by CNPq, CAPES, FAPEMIG, INCT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.